NERV
Minerva Neurosciences Inc
NASDAQ: NERV · HEALTHCARE · BIOTECHNOLOGY
$6.47
+1.25% today
Updated 2026-04-30
Market cap
$281.90M
P/E ratio
—
P/S ratio
1.87x
EPS (TTM)
$-34.67
Dividend yield
—
52W range
$1 – $9
Volume
0.3M
Minerva Neurosciences Inc (NERV) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-675.00%
ROA
-14.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | — | $-1.12M | — | — | — |
| 2012 | — | $-1.58M | — | — | — |
| 2013 | — | $-3.26M | — | — | — |
| 2014 | $0.00 | $-56.90M | — | — | — |
| 2015 | $0.00 | $-27.08M | — | — | — |
| 2016 | $0.00 | $-31.05M | — | — | — |
| 2017 | $0.00 | $-31.52M | — | — | — |
| 2018 | $0.00 | $-50.17M | — | — | — |
| 2019 | $41.18M | $-72.18M | -0.39% | -184.25% | -175.31% |
| 2020 | $41.18M | $1.94M | 100.00% | 4.49% | 4.71% |
| 2021 | $0.00 | $-49.91M | — | — | — |
| 2022 | $0.00 | $-32.11M | — | — | — |
| 2023 | $0.00 | $-30.01M | — | — | — |
| 2024 | $0.00 | $1.44M | — | — | — |
| 2025 | $0.00 | $-293.42M | — | — | — |